Product Name: Clindamycin hydrochloride CAS: 21462-39-5
Synonyms: (2S-TRANS)-METHYL 7-CHLORO-6,7,8-TRIDEOXY-6[[(1-METHYL-4-PROPYL-2-PYRROLIDINYL)CARBONYL]AMINO]-1-THIO-L-THREO-ALPHA-D-GALACTO-OCTOPYRANOSIDE; (7S)-7-CHLORO-7-DEOXYLINCOMYCIN HYDROCHLORIDE; 7(S)-CHLORO-7-DEOXYLINCOMYCIN; 7(S)-CHLORO-7-DEOXYLINCOMYCIN HCL; 7[S]-CHLORO-7-DEOXYLINCOMYCIN HYDROCHLORIDE; CLEOCIN; CLEOCIN HYDROCHLORIDE; CLINDAMYCIN HCL
CAS: 21462-39-5
MF: C18H34Cl2N2O5S
MW: 461.44
EINECS: 244-398-6
Product Categories: Antibiotic Explorer; Peptide Synthesis/Antibiotics; Carbohydrates & Derivatives; Heterocycles; Intermediates & Fine Chemicals; Pharmaceuticals; Sulfur & Selenium Compounds; CLINSOL; antibiotic
mp 141°C
storage temp. 2-8°C
solubility H2O: 50 mg/mL, clear, colorless
Chemical Properties White Solid
Usage : antibacterial, inhibits protein synthesis
Semi-synthetic antibiotic prepared from Lincomycin
Clindamycin hydrochloride is a salt of clindamycin, a semi-synthetic lincosamide. The hydrochloride salt forms at the basic N-ethylproline moiety and is the preferred pharmaceutical formulation. Like other members of the lincosamide family, clindamycin is a broad spectrum antibiotic with activity against anaerobic bacteria and protozoans. Clindamycin hydrochloride acts by binding to the 23S ribosomal subunit, blocking protein synthesis. Clindamycin hydrochloride has been extensively studied with over 8,000 literature citations.